BLOG.AIDS.GOV - Changing to in Spring 2017

Text SizePrint

NIH’s Dr. Carl Dieffenbach Shares Highlights from Thursday at AIDS 2014

At the conclusion of Thursday’s sessions at the 20th International AIDS Conference (AIDS 2014) Exit Disclaimer in Melbourne, Australia, we spoke again with Dr. Carl Dieffenbach from NIH/NIAID to hear his summary of conference highlights of the day.

Dr. Dieffenbach observed that much of the conversation on Thursday was around advances in HIV prevention and how to optimize deployment of all the tools available to prevent new HIV infections, including both treatment as prevention and pre-exposure prophylaxis (PrEP). He highlighted, as an example, a plenary presentation, “Stepping up the Pace on New Prevention Technologies,”Exit Disclaimer by Dr. Kenneth Mayer of Boston’s Fenway Health and Harvard Medical School. In addition to effectively deploying those tools, Dr. Mayer and others at the conference called for advancing research underway to develop new or better tools, including an HIV vaccine and vaginal ring to prevent HIV transmission. Additionally, researchers are studying novel means of delivering PrEP—such as injectables, implantables, and patches that would make PrEP easier to use and increase adherence. (Read more about vaccines and microbicides.)

carlWatch Dr. Dieffenbach’s remarks above. Check back tomorrow for Dr. Dieffenbach’s final conference observation from AIDS 2014.

About AIDS 2014

Gathered under the theme of “Stepping Up the Pace,” some 12,000 participants from 200 countries around the world have gathered in Melbourne for the 20th International AIDS Conference, known as AIDS 2014. This biennial gathering for those working in the field of HIV, including scientists, medical practitioners, activists, policymakers, people living with HIV and others committed to ending the epidemic. For more coverage from the conference visit AIDS 2014.